Trials / Unknown
UnknownNCT05277311
Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)
Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN): A Randomized, Double-Blind, Placebo-Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,376 (estimated)
- Sponsor
- Dongzhimen Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to determine if LongShengZhi Capsule is effective and safe in patients with ischemic stroke in comparison to placebo. This trial is a prospective, multicenter, randomized, placebo-controlled, double-blinded, parallel-group, superiority trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LongShengZhi capsule | LongShengZhi capsules, orally, 5 capsules each time, three times a day. |
| DRUG | LongShengZhi capsule placebo | LongShengZhi capsules placebo, orally, 5 capsules each time, three times a day. |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2023-12-31
- Completion
- 2024-06-30
- First posted
- 2022-03-14
- Last updated
- 2022-03-14
Source: ClinicalTrials.gov record NCT05277311. Inclusion in this directory is not an endorsement.